Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis

End-stage kidney disease (ESKD) has been shown to be correlated with an increased risk of COVID-19 infection and mortality. Remdesivir is an effective non-EUA U.S. Food and Drug Administration (FDA)-approved antiviral agent for the treatment of COVID-19 in hospitalized adult and pediatric patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Geffin, Ryan, Raheem, Shazia, Pandit, Lavannya M., Hunter, Andrew S., Holliday, Michael W., Rao, Aditya V., Shah, Maulin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515550/
https://www.ncbi.nlm.nih.gov/pubmed/37732474
http://dx.doi.org/10.1177/23247096231200386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515550/
https://www.ncbi.nlm.nih.gov/pubmed/37732474
http://dx.doi.org/10.1177/23247096231200386

Ejemplares similares